Clinical Trials
14 trialsNCT05044819 2026-06-01
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals
Phase 4 Active not recruiting
NCT05741372 2026-01-13
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
Boehringer Ingelheim
Phase NA Completed
NCT06812780 2025-09-24
CAMPOLINA
AstraZeneca
Phase 1 Completed
NCT06842563 2025-07-09
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
Singlera Genomics Inc.
Active not recruiting
NCT03878550 2025-03-13
Case-Control Study of the Glycotestâ„¢ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Glycotest, Inc.
Active not recruiting
NCT05683548 2025-02-17
RCAP
Replicor Inc.
No longer available
NCT05181826 2024-06-14
ELITE
Helio Genomics
Unknown
NCT05199259 2024-06-14
LIVER-1
Helio Genomics
Recruiting
NCT03694600 2024-05-31
CLiMB
Helio Genomics
Unknown
NCT01532427 2020-10-26
2011-AAR-004
Sequana Medical N.V.
Completed
NCT03804593 2020-01-30
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Epigenomics, Inc
Completed
NCT02289300 2020-01-13
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
A2 Healthcare Taiwan Corporation
Phase 2 Withdrawn
NCT02256514 2019-08-30
HCC
Immunitor LLC
Phase 2 Unknown
NCT01804829 2017-03-15
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
Phase 3 Completed